Editorials
Mass treatment with statins
BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4745 (Published 23 July 2014) Cite this as: BMJ 2014;349:g4745
Related articles
- Practice Published: 17 July 2014; BMJ 349 doi:10.1136/bmj.g4356
- Analysis Published: 14 October 2010; BMJ 341 doi:10.1136/bmj.c5146
- Analysis Published: 07 February 2012; BMJ 344 doi:10.1136/bmj.e55
- News Published: 11 June 2014; BMJ 348 doi:10.1136/bmj.g3937
- Editor's Choice Published: 24 July 2014; BMJ 349 doi:10.1136/bmj.g4793
- Letter Published: 09 July 2014; BMJ 349 doi:10.1136/bmj.g4130
- Letter Published: 29 April 2014; BMJ 348 doi:10.1136/bmj.g2940
- Letter Published: 03 September 2014; BMJ 349 doi:10.1136/bmj.g5081
- Letter Published: 03 September 2014; BMJ 349 doi:10.1136/bmj.g5082
- Editorial Published: 23 June 2015; BMJ 350 doi:10.1136/bmj.h3397
- Analysis Published: 09 October 2015; BMJ 351 doi:10.1136/bmj.h5260
- Endgames Published: 13 June 2016; BMJ 353 doi:10.1136/bmj.i3022
- Student Published: 17 December 2014; BMJ 349 doi:10.1136/sbmj.g7489
See more
- Rehabilitation after discharge from ICU is often poorly coordinated, NCEPOD findsBMJ June 13, 2025, 389 r1226; DOI: https://doi.org/10.1136/bmj.r1226
- NHS waiting list falls in England, but leaders warn of “long way to go”BMJ June 13, 2025, 389 r1222; DOI: https://doi.org/10.1136/bmj.r1222
- Training bottlenecks and unemployment—bad for doctors, patients, and the public purseBMJ June 12, 2025, 389 r1204; DOI: https://doi.org/10.1136/bmj.r1204
- NHS leaders say extra £29bn a year is not enough to cut waiting times and modernise servicesBMJ June 11, 2025, 389 r1213; DOI: https://doi.org/10.1136/bmj.r1213
- Scarlett McNally: Healthier environments and prevention can help us manage dementia betterBMJ June 11, 2025, 389 r1163; DOI: https://doi.org/10.1136/bmj.r1163
Cited by...
- Cost-Effectiveness Analysis of Statins, Berberine, and Their Combined Use for Primary Prevention of Cardiovascular Disease
- Accreditation drives teaching: evidence-based medicine and medical education standards
- Statins for primary prevention of cardiovascular disease: modelling guidelines and patient preferences based on an Irish cohort
- Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
- Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease
- Application of the 2014 NICE cholesterol guidelines in the English population: a cross-sectional analysis
- Assessment of cardiovascular risk in primary care
- Rethinking the appraisal and approval of drugs for type 2 diabetes
- Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study
- How medicine is broken, and how we can fix it
- Risky business: doctors' understanding of statistics
- NICE must do better at summarising and communicating evidence on statins
- Effective public health policies are not harder to fund than drugs or advice
- Clinical controversies to watch in 2015